Cargando…
Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations
Drug nanoformulations hold remarkable promise for the efficient delivery of therapeutics to a disease site. Unfortunately, artificial nanocarriers, mostly liposomes and polymeric nanoparticles, show limited applications due to the unfavorable pharmacokinetics and rapid clearance from the blood circu...
Autores principales: | Klyachko, Natalia L., Arzt, Camryn J., Li, Samuel M., Gololobova, Olesia A., Batrakova, Elena V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760239/ https://www.ncbi.nlm.nih.gov/pubmed/33271883 http://dx.doi.org/10.3390/pharmaceutics12121171 |
Ejemplares similares
-
Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
por: Zhao, Yuling, et al.
Publicado: (2022) -
Longitudinal characterization of circulating extracellular vesicles and small RNA during simian immunodeficiency virus infection and antiretroviral therapy
por: Huang, Yiyao, et al.
Publicado: (2023) -
Label‐free characterization of an extracellular vesicle‐based therapeutic
por: Priglinger, Eleni, et al.
Publicado: (2021) -
Extracellular Vesicles as Drug Carriers for Enzyme Replacement Therapy to Treat CLN2 Batten Disease: Optimization of Drug Administration Routes
por: Haney, Matthew J., et al.
Publicado: (2020) -
An ex vivo model of interactions between extracellular vesicles and peripheral mononuclear blood cells in whole blood
por: Rodriguez, Blanca V., et al.
Publicado: (2023)